INTERPARFUMS INC engaged Grant Thornton, LLP as its auditor.
“tion S-K, other than, as previously disclosed in Item 9A of the Company’s Annual Report on Form 10-K for the years ended December 31, 2025 and 2024, a material weakness in internal control over financial reporting On May 8, 2026, the Audit Committee appointed Grant Thornton, LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm.”
Auditor Changes
INTERPARFUMS INC dismissed Forvis Mazars, LLP as its auditor.
“as the Company’s independent registered public accounting firm effective May 8, 2026”
Earnings Releases
INTERPARFUMS INC reported first quarter ended March 31, 2026 results: revenue $ 345 Million, net income $ 43 million, EPS $ 1.35. Guidance reaffirmed.
“Interparfums, Inc. Reports 2026 First Quarter Results Q 1 2026 Net Sales of $ 345 Million and Diluted EPS of $ 1.35 Per Share; Reaffirms Full Year 2026 Guidance; Quarterly Cash Dividend to be Paid on June 30, 2026”
Earnings Releases
INTERPARFUMS INC reported financial results for three months ended March 31, 2026.
“Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced net sales for the three months ended March 31, 2026. Net Sales ($ in millions) Three Months Ended March 31, 2026 2025 % Change Total Interparfums, Inc. $345 $339 2%”
Earnings Releases
INTERPARFUMS INC reported first quarter ended March 31, 2024 results: revenue Net Sales $324, net income Net Income attributable to IP $41, EPS Diluted EPS $1.27. Guidance reaffirmed.
“the first quarter ended March 31, 2024. First Quarter 2024 Highlights: ($ in millions, except per share amounts) Three Months Ended March 31, 2024 2023 % Change Net Sales $324 $312 4% Gross Margin 62.5% 65.1% (260 bps) Operating Income $68 $90 (25%) Operating Margin 21.0% 29.0% (800 bps) Net Income attributable to IP $41 $54 (24%) Diluted EPS”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.